MALAT1 and central nervous system cancer: Recently, the Wang group (Chang et al. 2021) demonstrated that METTL3 promoted the malignant progression of IDH-wt gliomas while upregulating the expression of the lncRNA MALAT1 by enhancing its stability via m6 A modification.